Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01307020Phase 2Completed
Phase 2, randomised, double-blind trial of dexketoprofen trometamol and tramadol in acute pain (10 arms), sponsored by Menarini Group. Primary endpoint: Total Pain Relief Score at 6 Hours. Started Feb 2011; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01307020.